Dr. Judith Lin, MD

Dr. Lin practices at OSU Internal Medicine in Westerville, Ohio.

Dr. Lin's NPI, 1356769723, was assigned on April 2, 2014. Dr. Lin holds Ohio license 35135294.

Dr. Lin's primary practice is OSU Internal Medicine, at 6100 N Hamilton Rd, Westerville, OH 43081 in Franklin County. The practice phone is (614) 293-2229.

Dr. Lin's primary practice is OSU Internal Medicine in Westerville, Ohio. Dr. Lin is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Lin is licensed in Ohio.

CMS data shows 206 Medicare services from Dr. Lin across 4 procedure codes in 2024, for 140 Medicare patients. Medicare paid $15,704 for them. Every service was in an office.

CMS counts 140 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have arthritis, and 66% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 53, with 73% women.

In 2024, Dr. Lin wrote 1,339 Medicare Part D claims for 220 patients. 88% of them were for generic drugs. CMS names the drug for 1,198 of them, across 23 drugs with 11 or more claims each, at $580,132 in total drug cost. In 2023, CMS named 1,279 claims across 26 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 52 papers to Dr. Lin, published from 2008 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Vascular Surgical Procedures, Michigan and Arterial Occlusive Diseases. Dr. Lin has published most often in J Vasc Surg. Dr. Lin's most frequent co-authors are Loay S. Kabbani, MD, Alexander D. Shepard, MD and Abraham Moris Korman, MD.

CMS Open Payments shows 5 general payments to Dr. Lin from 3 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 84% of the total. Genentech, Inc. paid the most, $2,036.